Germany· DE-A57-d8d25bb53d59867e
Coffeinum N
A medicinal product containing anhydrous caffeine, registered in Germany by Cooper Consumer Health Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Anhydrous Caffeine
- Manufacturer
- Cooper Consumer Health Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Anhydrous caffeine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAlertL.N.K. International, Inc.
- United KingdomBeechams Active Cold Relief capletsHaleon UK Trading Ltd
- BelgiumAlgostase 500 mg - 50 mgLaboratoires S.M.B.
- FinlandCoffein EtnoviaEtnovia Oy
- SpainDURVITAN 300 mg CAPSULAS DURAS DE LIBERACION PROLONGADAAnotaciones Farmaceuticas S.L.
- FranceCITRATE DE CAFEINE COOPER 25 mg/mL, solution injectable et buvableCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- CzechiaGENCEBOKGennisium Pharma, Vitrolles
- CanadaCAFFEINE CITRATE INJECTION USPOMEGA LABORATORIES LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Coffekapton
- Belgium · Cafeine Sterop
- Spain · Durvitan
- France · Citrate De Cafeine Cooper, Percutafeine
- United Kingdom (Northern Ireland) · Caffeine Citrate, Caffeine Citrate Brown & Burk Uk
- Hungary · Coffeini Fono Viii. Naturland
- Iceland · Gencebok, Peyona
- Italy · Caffeina Citrato Monico
- Liechtenstein · Gencebok, Peyona
- Malta · Caffeine Citrate Monico
- Norway · Gencebok, Peyona
- Sweden · Koffein Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/daff4055-3e67-46b6-ae14-bd4462ee7ef6 GET /v1/drugs/daff4055-3e67-46b6-ae14-bd4462ee7ef6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Anhydrous Caffeine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about anhydrous caffeine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.